Bulk Manufacturer of Controlled Substances Application: MALLINCKRODT LLC, 4592 [2015-01576]
Download as PDF
<![CDATA[
4592
ACTION:
Federal Register / Vol. 80, No. 18 / Wednesday, January 28, 2015 / Notices
Notice of Open Meeting.
DEPARTMENT OF JUSTICE
The Advisory Committee on
Rules of Evidence will hold a one-day
meeting. The meeting will be open to
public observation but not participation.
SUMMARY:
April 17, 2015.
Time: 8:30 a.m. to 5:00 p.m.
DATES:
Fordham University, School
of Law, 150 West 62nd Street, New
York, New York 10023.
ADDRESSES:
FOR FURTHER INFORMATION CONTACT:
Jonathan C. Rose, Rules Committee
Secretary, Rules Committee Support
Office, Administrative Office of the
United States Courts, Washington, DC
20544, telephone (202) 502–1820.
BILLING CODE 2210–55–P
JUDICIAL CONFERENCE OF THE
UNITED STATES
Judicial Conference of the
United States, Advisory Committee on
Rules of Criminal Procedure.
AGENCY:
Notice of open meeting.
The Advisory Committee on
Rules of Criminal Procedure will hold a
two-day meeting. The meeting will be
open to public observation but not
participation.
SUMMARY:
March 16–17, 2015.
Time: 8:30 a.m. to 5 p.m.
DATES:
Florida A&M University,
College of Law, 201 Beggs Avenue,
Orlando, Florida 32801.
ADDRESSES:
FOR FURTHER INFORMATION CONTACT:
Jonathan C. Rose, Rules Committee
Secretary, Rules Committee Support
Office, Administrative Office of the
United States Courts, Washington, DC
20544, telephone (202) 502–1820.
mstockstill on DSK4VPTVN1PROD with NOTICES
Bulk Manufacturer of Controlled
Substances Application:
MALLINCKRODT LLC
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
ACTION:
Notice of application.
[Docket No. DEA–392]
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration in
accordance with 21 CFR 1301.33(a) on
or before March 30, 2015.
DATES:
The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Deputy Assistant
Administrator of the DEA Office of
Diversion Control (‘‘Deputy Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart, R.
In accordance with 21 CFR
1301.33(a), this is notice that on May 20,
2014, Mallinckrodt LLC, 3600 North
Second Street, St. Louis, Missouri
63147, applied to be registered as a bulk
manufacturer of the following basic
classes of controlled substances:
SUPPLEMENTARY INFORMATION:
Meeting of the Judicial Conference
Committee on Rules of Practice and
Procedure
Controlled substance
Dated: January 23, 2015.
Jonathan C. Rose,
Rules Committee Secretary.
[FR Doc. 2015–01564 Filed 1–27–15; 8:45 am]
BILLING CODE 2210–55–P
16:41 Jan 27, 2015
BILLING CODE P
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/ODW, 8701
Morrissette Drive, Springfield, Virginia
22152. Request for hearings should be
sent to: Drug Enforcement
Administration, Attention: Hearing
Clerk/LJ, 8701 Morrissette Drive,
Springfield, Virginia 22152.
[FR Doc. 2015–01565 Filed 1–27–15; 8:45 am]
VerDate Sep<11>2014
[FR Doc. 2015–01576 Filed 1–27–15; 8:45 am]
[Docket No. DEA–392]
ADDRESSES:
Dated: January 23, 2015.
Jonathan C. Rose,
Rules Committee Secretary.
ACTION:
Drug Enforcement Administration
Gamma
Hydroxybutyric
Acid
(2010).
Lisdexamfetamine (1205) .............
Schedule
I
II
The company plans to manufacturer
bulk active pharmaceutical ingredients
(API) for distribution and product
development to its customers.
Jkt 235001
Dated: January 21, 2015.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
PO 00000
Frm 00064
Fmt 4703
Sfmt 4703
Importer of Controlled Substances
Application: Cambrex Charles City
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration in
accordance with 21 CFR 1301.34(a) on
or before February 27, 2015. Such
persons may also file a written request
for a hearing on the application
pursuant to 21 CFR 1301.43 on or before
February 27, 2015.
DATES:
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/ODW, 8701
Morrissette Drive, Springfield, Virginia
22152. Comments and requests for
hearings on applications to import
narcotic raw materials are not
appropriate. 72 FR 3417 (January 25,
2007).
ADDRESSES:
The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Deputy Assistant
Administrator of the DEA Office of
Diversion Control (‘‘Deputy Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.34(a), this is notice that on May 15,
2014, Cambrex Charles City, 1205 11th
Street, Charles City, Iowa 50616–3466,
applied to be registered as an importer
of the following basic classes of
controlled substances:
SUPPLEMENTARY INFORMATION:
E:\FR\FM\28JAN1.SGM
28JAN1
]]>Agencies
[Federal Register Volume 80, Number 18 (Wednesday, January 28, 2015)]
[Notices]
[Page 4592]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2015-01576]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Bulk Manufacturer of Controlled Substances Application:
MALLINCKRODT LLC
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic classes, and
applicants therefore, may file written comments on or objections to the
issuance of the proposed registration in accordance with 21 CFR
1301.33(a) on or before March 30, 2015.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/ODW,
8701 Morrissette Drive, Springfield, Virginia 22152. Request for
hearings should be sent to: Drug Enforcement Administration, Attention:
Hearing Clerk/LJ, 8701 Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: The Attorney General has delegated his
authority under the Controlled Substances Act to the Administrator of
the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority
to exercise all necessary functions with respect to the promulgation
and implementation of 21 CFR part 1301, incident to the registration of
manufacturers, distributors, dispensers, importers, and exporters of
controlled substances (other than final orders in connection with
suspension, denial, or revocation of registration) has been redelegated
to the Deputy Assistant Administrator of the DEA Office of Diversion
Control (``Deputy Assistant Administrator'') pursuant to section 7 of
28 CFR part 0, appendix to subpart, R.
In accordance with 21 CFR 1301.33(a), this is notice that on May
20, 2014, Mallinckrodt LLC, 3600 North Second Street, St. Louis,
Missouri 63147, applied to be registered as a bulk manufacturer of the
following basic classes of controlled substances:
------------------------------------------------------------------------
Controlled substance Schedule
------------------------------------------------------------------------
Gamma Hydroxybutyric Acid (2010)........... I
Lisdexamfetamine (1205).................... II
------------------------------------------------------------------------
The company plans to manufacturer bulk active pharmaceutical
ingredients (API) for distribution and product development to its
customers.
Dated: January 21, 2015.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
[FR Doc. 2015-01576 Filed 1-27-15; 8:45 am]
BILLING CODE P
